These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29575075)

  • 1. Adverse events reported to the Food and Drug Administration from 2004 to 2016 for cosmetics and personal care products marketed to newborns and infants.
    Cornell E; Kwa M; Paller AS; Xu S
    Pediatr Dermatol; 2018 Mar; 35(2):225-229. PubMed ID: 29575075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Cosmetic Reactions in a Pediatric Population Reported to the Chongqing Drug Administration in China From 2017 to 2021.
    Wang S; Lyu J; Jiang Y; Li J; Diao Q
    Dermatitis; 2024; 35(4):361-365. PubMed ID: 38126876
    [No Abstract]   [Full Text] [Related]  

  • 3. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time for a makeover-cosmetics regulation in the United States.
    Cornell EM; Janetos TM; Xu S
    J Cosmet Dermatol; 2019 Dec; 18(6):2041-2047. PubMed ID: 30950176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration.
    Jacob SL; Cornell E; Kwa M; Funk WE; Xu S
    JNCI Cancer Spectr; 2018 Apr; 2(2):pky012. PubMed ID: 31360845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.
    Clark JA; Humphries JE; Crean S; Reynolds MW
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):107-14. PubMed ID: 20014051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notification of undesirable effects of cosmetics and toiletries.
    Sportiello L; Cammarota S; de Portu S; Sautebin L
    Pharmacol Res; 2009 Feb; 59(2):101-6. PubMed ID: 19028583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.
    Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events Reported to the United States Food and Drug Administration Related to Caffeine-Containing Products.
    Jagim AR; Harty PS; Fischer KM; Kerksick CM; Erickson JL
    Mayo Clin Proc; 2020 Aug; 95(8):1594-1603. PubMed ID: 32753134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reported adverse drug events in infants and children under 2 years of age.
    Moore TJ; Weiss SR; Kaplan S; Blaisdell CJ
    Pediatrics; 2002 Nov; 110(5):e53. PubMed ID: 12415059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database.
    Gandhi PK; Gentry WM; Bottorff MB
    Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration.
    Hartnell NR; Wilson JP
    Pharmacotherapy; 2004 Jun; 24(6):743-9. PubMed ID: 15222664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Cosmetics in the United States.
    Katz LM; Lewis KM; Spence S; Sadrieh N
    Dermatol Clin; 2022 Jul; 40(3):307-318. PubMed ID: 35750414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel database for exposure to fragrance ingredients in cosmetics and personal care products.
    Comiskey D; Api AM; Barratt C; Daly EJ; Ellis G; McNamara C; O'Mahony C; Robison SH; Safford B; Smith B; Tozer S
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):660-72. PubMed ID: 26003515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular Adverse Effects of Over-the-Counter Cosmetics and Personal Care Products Reported to the Food and Drug Administration.
    Zhu A; Aftab OM; Mahajan J; Burkat CN
    Ophthalmic Plast Reconstr Surg; 2024 Aug; ():. PubMed ID: 39136955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Supplement Adverse Event Report Data From the FDA Center for Food Safety and Applied Nutrition Adverse Event Reporting System (CAERS), 2004-2013.
    Timbo BB; Chirtel SJ; Ihrie J; Oladipo T; Velez-Suarez L; Brewer V; Mozersky R
    Ann Pharmacother; 2018 May; 52(5):431-438. PubMed ID: 29171279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of high-risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016.
    Janetos TM; Akintilo L; Xu S
    J Cosmet Dermatol; 2019 Oct; 18(5):1361-1365. PubMed ID: 30565865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.